Status | Study |
Not yet recruiting |
Study Name: Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2016-11-09 Interventions: Other: Ultrasound UHF peripheral nerves Ot |
Recruiting |
Study Name: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-11-02 Interventions: Biological: HYQVIA Other Names: IGI 10% with rHuPH20 Immune Gl |
Not yet recruiting |
Study Name: Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-08-29 Interventions: Procedure: Muscle Magnetic Resonance Imaging (RMI) evaluation |
Not yet recruiting |
Study Name: Processing Integration in Neurological Patients Using fMRI Condition: Acute Inflammatory Demyelinating Polyradiculoneuropathy Stroke Date: 2016-03-23 Interventions: Device: 3 Tesla Siemens Skyra MRI scanner Standardly used Magnetic resonance imaging (MRI) protocols, in |
Recruiting |
Study Name: Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Condition: CIDP Date: 2015-12-10 Interventions: Other: CIDP treated (IVIG) usual treatment with intravenous immunoglobulin |
Recruiting |
Study Name: Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2015-09-11 Interventions: Biological: HYQVIA Dosing regi |
Withdrawn |
Study Name: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2015-08-30 Interventions: Drug: H.P. Acthar® Gel Other Names: Acthar® Gel repo |
Recruiting |
Study Name: Transcriptome Analysis of the Peripheral Blood in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Autoi Date: 2015-02-06 Interventions: Drug: IVIg |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-12-11 Interventions: Drug: I10E Patients who met all eligibility criteria will receive 0.5 g/kg of IMP every 3 weeks during 4 |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-11-13 Interventions: Drug: I10E Patients who meet all eligibility criteria will |